Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes

被引:0
|
作者
De Luca, A [1 ]
Vendittelli, M
Boldini, F
Di Giambenedetto, S
Trotta, MP
Cingolani, A
Bacarelli, A
Gori, C
Perno, CF
Antinori, A
Ulivi, G
机构
[1] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy
[2] Univ Roma La Sapienza, Dept Comp & Syst Sci, Rome, Italy
[3] IRCCS, Natl Inst Infect Dis, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[5] Univ Roma Tor Vergata, Dept Comp Sci & Automat, Rome, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To evaluate whether fuzzy operators can be usefully applied to the interpretation of genotypic HIV-1 drug resistance by experts, and to improve the prediction of salvage therapy outcome by adapting interpretation rules of genotypic resistance on the basis of their association with virological response data. Methods: We used a clinical dataset of 231 patients failing highly active antiretroviral therapy (HAART) and starting salvage therapy with baseline resistance genotyping and virological outcomes after 3 and 6 months. A set of rules predicting genotypic resistance was initially derived from an expert (ADL). Rules were implemented using a fuzzy logic approach and the virological outcomes dataset used for the training phase. The resulting algorithm was validated using a separate set of 184 selected patients by correlating the resulting predicted activity with observed virological response at 3 months. For comparison, the expert systems from the drug resistance group of the Agence Nationale de Recherches sur le SIDA (ANRS-AC11) and the algorithm from the Stanford's HIV drug resistance database (Stanford HIVdb) were evaluated on the same set. Results: The starting algorithm had a correlation with virological outcomes of R-2 = 0.06 (P = 0.0001). After the training phase the correlation with virological outcomes increased to R-2 = 0.19 (p < 0.000001). In the validation set of patients, the activity of the salvage regimen predicted by the fuzzy algorithm was the only variable independently predictive of the 3-month viral load change even after adjusting by the activity predicted by the two expert systems and baseline viral load (for each 10% salvage regimen's activity increase, mean HIV RNA change from baseline: -0.27 log(10) copies/ml; 95% CI -0.39, -0.15). Conclusion: Using fuzzy operators in a virological outcomes training database to implement a rules-based algorithm for genotypic resistance interpretation, significant improvements of outcomes prediction were obtained. The resulting algorithm showed an independent predictive capability of virological outcomes over that of two rules-based interpretation algorithms made by experts. Although the system was trained and validated on a limited number of cases, the approach deserves further evaluation.
引用
收藏
页码:583 / 593
页数:11
相关论文
共 50 条
  • [1] Construction, training and clinical validation of an inferential interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules learning from virological outcomes
    De Luca, A
    Vendittoli, M
    Baldini, F
    Di Giambenedetto, S
    Rizzo, MG
    Trotta, MP
    Cingolani, A
    Forbici, F
    Perno, CF
    Antinori, A
    Ulivi, G
    ANTIVIRAL THERAPY, 2002, 7 : S94 - S94
  • [2] Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems
    De Luca, A
    Cozzi-Lepri, A
    Perno, CF
    Balotta, C
    Di Giambenedetto, S
    Poggio, A
    Pagano, G
    Tositti, G
    Piscopo, R
    Del Forno, A
    Chiodo, F
    Magnanio, G
    Monforte, AD
    ANTIVIRAL THERAPY, 2004, 9 (05) : 743 - 752
  • [3] Interpretation systems for genotypic drug resistance of HIV-1
    De Luca, A
    Antinori, A
    Di Giambenedetto, S
    Cingolani, A
    Colafigli, M
    Perno, CF
    Cauda, R
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 : 29 - 34
  • [4] HIV-1 Genotypic Drug Resistance Interpretation Rules-2009 Spanish Guidelines
    de Mendoza, Carmen
    Anta, Lourdes
    Garcia M, Federico
    Perez-Elias, Jesus
    Gutierrez, Felix
    Llibre, Josep Ma
    Menendez-Arias, Luis
    Dalmau, David
    Soriano, Vincent
    AIDS REVIEWS, 2009, 11 (01) : 39 - 51
  • [5] Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score
    De Luca, Andrea
    Di Giambenedetto, Simona
    Maserati, Renato
    Gianotti, Nicola
    Narciso, Pasquale
    Antinori, Andrea
    Di Perri, Giovanni
    Prosperi, Mattia C. F.
    Baldanti, Fausto
    Micheli, Valeria
    Zazzi, Maurizio
    Perno, Carlo F.
    Santoro, Maria M.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 489 - 497
  • [6] Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
    Frentz, Dineke
    Boucher, Charles A. B.
    Assel, Matthias
    De Luca, Andrea
    Fabbiani, Massimiliano
    Incardona, Francesca
    Libin, Pieter
    Manca, Nino
    Mueller, Viktor
    Nuallain, Breanndan O.
    Paredes, Roger
    Prosperi, Mattia
    Quiros-Roldan, Eugenia
    Ruiz, Lidia
    Sloot, Peter M. A.
    Torti, Carlo
    Vandamme, Anne-Mieke
    Van Laethem, Kristel
    Zazzi, Maurizio
    van de Vijver, David A. M. C.
    PLOS ONE, 2010, 5 (07):
  • [7] The HIVdb System for HIV-1 Genotypic Resistance Interpretation
    Tang, Michele W.
    Liu, Tommy F.
    Shafer, Robert W.
    INTERVIROLOGY, 2012, 55 (02) : 98 - 101
  • [8] Algorithms for the interpretation of HIV-1 genotypic drug resistance information
    Vercauteren, Jurgen
    Vandamme, Anne-Mieke
    ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 335 - 342
  • [9] Extensive HIV-1 antiretroviral drug class resistance is associated with inferior virological and clinical outcomes
    Napravnik, S.
    Keys, J.
    Stalzer, B.
    Eron, J. J.
    ANTIVIRAL THERAPY, 2007, 12 : S68 - S68
  • [10] Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting
    Zazzi, Maurizio
    Prosperi, Mattia
    Vicenti, Ilaria
    Di Giambenedetto, Simona
    Callegaro, Annapaola
    Bruzzone, Bianca
    Baldanti, Fausto
    Gonnelli, Angela
    Boeri, Enzo
    Paolini, Elisabetta
    Rusconi, Stefano
    Giacometti, Andrea
    Maggiolo, Franco
    Menzo, Stefano
    De Luca, Andrea
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (03) : 616 - 624